Lataa...
Target of rapamycin inhibitors (TOR‐I; sirolimus and everolimus) for primary immunosuppression in kidney transplant recipients
BACKGROUND: Kidney transplantation is the therapy of choice for many patients with end‐stage kidney disease (ESKD) with an improvement in survival rates and satisfactory short term graft survival. However, there has been little improvement in long‐term survival. The place of target of rapamycin inhi...
Tallennettuna:
| Julkaisussa: | Cochrane Database Syst Rev |
|---|---|
| Päätekijät: | , , , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
John Wiley & Sons, Ltd
2019
|
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6953317/ https://ncbi.nlm.nih.gov/pubmed/31840244 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD004290.pub3 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|